A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies

Clinical trial NCT05209295 · TERMINATED

Trial details

NCT number: NCT05209295
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Insufficiency Neoplasms

Start date: 2024-07-12
Primary completion: 2025-04-20
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.